新闻|股票|评论|外汇|债券|基金|期货|黄金|银行|保险|数据|行情|信托|理财|区块链|汽车|房产|科技|视频|博客
|直播|财道
|农金

简称:万泰生物 代码:603392


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计5,750,329,074.69817,710,610.154,932,618,464.5485.78
其他(补充)48,339,038.269,563,882.4938,775,155.7780.21
体外诊断2,339,297,546.39557,547,368.821,781,750,177.5776.17
疫苗3,362,692,490.04250,599,358.843,112,093,131.2092.55

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,354,256,829.93442,141,668.501,912,115,161.4381.22
其他(补充)17,142,805.123,428,307.9113,714,497.2180.00
体外诊断1,471,533,543.04348,570,817.031,122,962,726.0176.31
疫苗865,580,481.7790,142,543.56775,437,938.2189.59

会计年度:2020-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销-71,056,901.85-67,867,237.77-3,189,664.084.49
合计843,715,896.65179,662,302.37664,053,594.2878.71
其他(补充)120,112,006.6027,826,395.5492,285,611.0676.83
试剂分部625,756,668.71143,843,517.73481,913,150.9877.01
仪器分部87,945,661.0970,327,955.2317,617,705.8620.03
疫苗分部80,958,462.105,531,671.6475,426,790.4693.17